BOVE, GUGLIELMO
 Distribuzione geografica
Continente #
EU - Europa 136
NA - Nord America 111
AS - Asia 29
Totale 276
Nazione #
US - Stati Uniti d'America 108
IT - Italia 74
IE - Irlanda 49
SG - Singapore 17
CN - Cina 7
FI - Finlandia 5
CA - Canada 3
DE - Germania 3
KR - Corea 2
NL - Olanda 2
FR - Francia 1
IL - Israele 1
IN - India 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
Totale 276
Città #
Dublin 49
Chandler 30
Singapore 17
Naples 15
Aversa 13
Boardman 13
New York 12
Santa Clara 9
Ercolano 4
Pomigliano d'Arco 4
Rome 4
Beijing 3
Elora 3
Helsinki 3
Pisa 3
Positano 3
Salerno 3
San Giorgio a Cremano 3
Bacoli 2
Fisciano 2
Lappeenranta 2
Milan 2
Roxbury 2
Seoul 2
Amsterdam 1
Avellino 1
Bologna 1
Boydton 1
Bremen 1
Brescia 1
Cambridge 1
Colombo 1
Florence 1
Munich 1
Piscataway 1
Princeton 1
Pune 1
Rehovot 1
Riga 1
Sandefjord 1
Shenzhen 1
Striano 1
Volla 1
Totale 222
Nome #
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 52
Epi-Drugs Targeting RNA Dynamics in Cancer 45
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? 35
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A 33
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 31
The m6A-independent role of epitranscriptomic factors in cancer 29
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis 29
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance 25
Epitranscriptomics and epigenetics: two sides of the same coin? 8
Totale 287
Categoria #
all - tutte 1.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 0 0 0 0 7
2022/2023120 9 4 10 11 13 10 1 4 53 1 0 4
2023/202488 6 7 2 13 14 16 3 6 1 1 7 12
2024/202572 17 11 9 14 21 0 0 0 0 0 0 0
Totale 287